Latest accounts payable for MLPH: $32K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Molecular Pharmacology (USA), (MLPH) currently reports a accounts payable of $32K as of September 2014. That compares with $34K in the prior-year period — down 7.0% year over year. Use the charts on this page to explore Molecular Pharmacology (USA),'s accounts payable history and peer comparisons.
Molecular Pharmacology (USA),'s accounts payable decreased from $34K to $32K — a 7.0% year-over-year decrease (period ending September 2014). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Molecular Pharmacology (USA), reported $32K in accounts payable as of September 2014. That compares with $34K in the prior-year period — down 7.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current accounts payable of $32K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Molecular Pharmacology (USA),, and consider following MLPH for alerts when major investors trade the stock.